Image

Database ITANET - ENETS Registry

Database ITANET - ENETS Registry

Recruiting
19 years and older
All
Phase N/A

Each participating site will have access through the reserved area of webpage www.ita-net.org, where a proper link is enabled for the data recording in a database which ENETS set-up for the participating Sites in Europe, the ENETS-registry (https://www.enets-registry.eu/enets/).

The eligible patients, visited at each participating site, will be asked to adhere to the ENETS-project through a proper Informed Consent obtainment procedure.

The data will be collected in an anonymised way. Each patient will be identified by a code.

The data management and quality check of the Italian data is deputed to ITANET. The data will be collected in a prospective way, both for the new diagnoses (first visits) and for the follow up visits of patients with already acquired diagnosis. The enrolment will take place during the outpatient visit or at the time of the hospitalisation for the NET-related surgery.

Of course, considering the observational nature of the study, the follow up visits will be planned on the basis of each patient's clinical need, which is different patient by patient, according to the disease staging, the primary tumour location, the eventual surgery.

The data flow will be the following:

  • The participating site records the data in the database, waiting to be validated;
  • ITANET has the role to check the recorded data for completeness and coherence in order to decide whether:
    1. The data are acceptable: in this case the validated data will be acquired from ENETS-registry;
    2. There are discrepancies: in this case a query will be sent to the related site in order to check, correct/explain where applicable and to resubmit the data. The process starts again until final validation.

The data will be collected yearly to provide several information, such as:

  • Type of NETs followed by the reference national sites for the management of the study pathology;
  • Tools used for the diagnosis definition and the disease staging;
  • Therapeutic approach (surgical or medical);
  • Disease trend during follow up.
Study details
    Gastro-entero Pancreatic Neuroendocrine Tumors

NCT04282083

Italian Association Neuroendocrine Tumors

19 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.